★★★★

GemVax & KAEL

GemVax Largest Shareholder Gem&Company Partially Repays Stock-Backed Loan and Adds More Pledged Shares, Total Pledged Reaches 5.45 Million Shares... Risk of Equity Stake Dropping to 0.01% if Pledges Exercised


  • The largest shareholder Gem&Company has partially repaid the existing stock-backed loan No.1, resetting the balance to 19 billion won, and extended contract No.7 by three months, currently operating a total of 12 pledge contracts.
  • With this amendment, cumulative pledged shares increased from 5,229,974 to 5,449,974 shares, an increase of 220,000 shares. If all pledges are exercised, the largest shareholder's stake would drop from 12.32% to 0.01%, effectively losing control.
  • Gem&Company's financials show total assets of 12.8 billion won, total liabilities of 88.0 billion won, negative equity of -75.2 billion won, and a net loss of 13.6 billion won, indicating severe financial distress.
  • [AI Summary]The high pledge ratio and weak financial structure of the largest shareholder make a change in control a realistic risk. Although debt decreased slightly, the extension is short-term without a fundamental solution, leaving uncertainty. A drop in the stock price could trigger pledge execution and a massive sell-off.

KOSDAQ Filing Information


  • [Correction of Description] Execution of Stock Pledge Agreement Involving Change of Largest Shareholder
  • Company: GemVax & KAEL (082270)
  • Submission: GemVax & KAEL Co.,Ltd.
  • Under KRX KOSDAQ Market Division

  • Shares: 44,269,203
  • Price: 10,390 KRW
  • Market Cap: 460 B KRW